155 related articles for article (PubMed ID: 28660822)
1. Comparison of prognostic scoring systems in follicular thyroid cancer.
Teo KW; Yuan NK; Tan WB; Parameswaran R
Ann R Coll Surg Engl; 2017 Jul; 99(6):479-484. PubMed ID: 28660822
[TBL] [Abstract][Full Text] [Related]
2. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
3. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
5. Are prognostic scoring systems of value in patients with follicular thyroid carcinoma?
Ríos A; Rodríguez JM; Ferri B; Matínez-Barba E; Febrero B; Parrilla P
Eur J Endocrinol; 2013 Dec; 169(6):821-7. PubMed ID: 24050927
[TBL] [Abstract][Full Text] [Related]
6. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
7. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.
Jukkola A; Bloigu R; Ebeling T; Salmela P; Blanco G
Endocr Relat Cancer; 2004 Sep; 11(3):571-9. PubMed ID: 15369456
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of differentiated thyroid carcinoma staging systems in a Spanish population].
Andía Melero VM; Martín de Santa-Olalla Llanes M; Sambo Salas M; Percovich Hualpa JC; Motilla de la Cámara M; Collado Yurrita L
Endocrinol Nutr; 2015 Apr; 62(4):152-60. PubMed ID: 25744071
[TBL] [Abstract][Full Text] [Related]
12. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Wong RM; Bresee C; Braunstein GD
Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer.
Davis NL; Bugis SP; McGregor GI; Germann E
Am J Surg; 1995 Nov; 170(5):476-80. PubMed ID: 7485736
[TBL] [Abstract][Full Text] [Related]
14. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
[TBL] [Abstract][Full Text] [Related]
15. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
[No Abstract] [Full Text] [Related]
16. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
17. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Endocr Relat Cancer; 2007 Mar; 14(1):29-42. PubMed ID: 17395973
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.
van Velsen EFS; Peeters RP; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Visser WE; Verburg FA
Eur J Endocrinol; 2022 Feb; 186(3):389-397. PubMed ID: 35038308
[TBL] [Abstract][Full Text] [Related]
20. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma.
Kim HJ; Sung JY; Oh YL; Kim JH; Son YI; Min YK; Kim SW; Chung JH
Head Neck; 2014 Dec; 36(12):1695-700. PubMed ID: 24115217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
